136 related articles for article (PubMed ID: 2790773)
1. Cytogenetic analysis in essential thrombocythemia at diagnosis and at transformation. A 12-year study.
Sessarego M; Defferrari R; Dejana AM; Rebuttato AM; Fugazza G; Salvidio E; Ajmar F
Cancer Genet Cytogenet; 1989 Nov; 43(1):57-65. PubMed ID: 2790773
[TBL] [Abstract][Full Text] [Related]
2. Leukemic transformation with trisomy 8 in essential thrombocythemia: a report of four cases.
Hirose Y; Masaki Y; Sugai S
Eur J Haematol; 2002 Feb; 68(2):112-6. PubMed ID: 12061320
[TBL] [Abstract][Full Text] [Related]
3. Cytogenetic findings in untreated patients with essential thrombocythemia.
Panani AD
In Vivo; 2006; 20(3):381-4. PubMed ID: 16724675
[TBL] [Abstract][Full Text] [Related]
4. Cytogenetic abnormalities in essential thrombocythemia: prevalence and prognostic significance.
Gangat N; Tefferi A; Thanarajasingam G; Patnaik M; Schwager S; Ketterling R; Wolanskyj AP
Eur J Haematol; 2009 Jul; 83(1):17-21. PubMed ID: 19236446
[TBL] [Abstract][Full Text] [Related]
5. Cytogenetic abnormalities in essential thrombocythemia at presentation and transformation.
Sever M; Kantarjian H; Pierce S; Jain N; Estrov Z; Cortes J; Verstovsek S
Int J Hematol; 2009 Nov; 90(4):522-525. PubMed ID: 19728024
[TBL] [Abstract][Full Text] [Related]
6. Chromosome 11 rearrangement at band 11q21 in a patient with essential thrombocythemia.
Nakamura H; Hayashibara T; Kawachi T; Nagai K; Matsuo T; Sadamori N; Tomonaga M
Cancer Genet Cytogenet; 1992 Jan; 58(1):105-7. PubMed ID: 1728943
[TBL] [Abstract][Full Text] [Related]
7. Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.
Emilia G; Sacchi S; Temperani P; Longo R; Vecchi A
Leuk Lymphoma; 1993 Mar; 9(4-5):423-6. PubMed ID: 8348078
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetics of acutely transformed chronic myeloproliferative syndromes without a Philadelphia chromosome. A multicenter study of 55 patients. Groupe Français de Cytogénétique Hématologique.
Cancer Genet Cytogenet; 1988 Jun; 32(2):157-68. PubMed ID: 3163258
[TBL] [Abstract][Full Text] [Related]
9. Unusual chromosome aberration, t(13;14)(q32;q32.3), in a case of essential thrombocythemia with extreme thrombocytosis.
Mitev L; Georgiev G; Petrov A; Manolova Y
Cancer Genet Cytogenet; 1996 Oct; 91(1):68-70. PubMed ID: 8908170
[TBL] [Abstract][Full Text] [Related]
10. De novo appearance of der(1;7)(q10;p10) is associated with leukemic transformation and unfavorable prognosis in essential thrombocythemia.
Hsiao HH; Ito Y; Sashida G; Ohyashiki JH; Ohyashiki K
Leuk Res; 2005 Nov; 29(11):1247-52. PubMed ID: 16164981
[TBL] [Abstract][Full Text] [Related]
11. Acute biphenotypic leukemia arising in a patient with essential thrombocythemia.
Wong GC; Lee LH
Am J Hematol; 2006 Aug; 81(8):624-6. PubMed ID: 16823822
[TBL] [Abstract][Full Text] [Related]
12. Clinical presentation and natural history of patients with essential thrombocythemia and the Philadelphia chromosome.
Stoll DB; Peterson P; Exten R; Laszlo J; Pisciotta AV; Ellis JT; White P; Vaidya K; Bozdech M; Murphy S
Am J Hematol; 1988 Feb; 27(2):77-83. PubMed ID: 3422539
[TBL] [Abstract][Full Text] [Related]
13. Philadelphia chromosome positive essential thrombocythemia evolving into lymphoid blast crisis.
Paietta E; Rosen N; Roberts M; Papenhausen P; Wiernik PH
Cancer Genet Cytogenet; 1987 Apr; 25(2):227-31. PubMed ID: 3470113
[TBL] [Abstract][Full Text] [Related]
14. Analysis of clinical characteristics of bone marrow proliferative tumor progression to acute myeloid leukemia.
Li Y; Zhang XY; Han J; Wang L
Cancer Biomark; 2018; 23(4):469-472. PubMed ID: 30452397
[TBL] [Abstract][Full Text] [Related]
15. Philadelphia (Ph) chromosome-positive thrombocythemia without features of chronic myeloid leukemia in peripheral blood: natural history and diagnostic differentiation from Ph-negative essential thrombocythemia.
Michiels JJ; Berneman Z; Schroyens W; Kutti J; Swolin B; Ridell B; Fernando P; Zanetto U
Ann Hematol; 2004 Aug; 83(8):504-12. PubMed ID: 15164229
[TBL] [Abstract][Full Text] [Related]
16. Chromosomal aberrations during progression of chronic myeloid leukemia identified by cytogenetic and molecular cytogenetic tools: implication of 1q12-21.
Su XY; Wong N; Cao Q; Yu LZ; Niu C; Wickham N; Johnson PJ; Chen Z; Chen SJ
Cancer Genet Cytogenet; 1999 Jan; 108(1):6-12. PubMed ID: 9973917
[TBL] [Abstract][Full Text] [Related]
17. [Leukemic risk in thrombocythemia].
Liozon E; Turlure P
Ann Med Interne (Paris); 1998 Mar; 149(2):82-6. PubMed ID: 11490529
[TBL] [Abstract][Full Text] [Related]
18. Essential thrombocythemia terminating in acute leukemia with minimal myeloid differentiation--a brief review of recent literature.
Shibata K; Shimamoto Y; Suga K; Sano M; Matsuzaki M; Yamaguchi M
Acta Haematol; 1994; 91(2):84-8. PubMed ID: 8023650
[TBL] [Abstract][Full Text] [Related]
19. t(1;2), inv(1) and trisomy 1q during the blastic phase of Philadelphia chromosome-positive chronic myeloid leukemia.
Carbone P; Barbata G; Santoro A; Giglio MC; Mirto S; Granata G
Acta Haematol; 1987; 77(4):198-202. PubMed ID: 3115029
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
Panani AD
Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
